Conference Chairs

Dr. Abed Agbarya, Israel I Conference Co-Chair

Current Work:

  1. Head of Oncology, Bnai Zion Medical Center, Haifa, Israel.
  2. Director of the Community Oncology Program, Clalit Health Services. Nazareth, Israel

Professional Experience:

2016: Foundation and Consultant, Oncology Unit, Bnai Zion MC, Haifa. (Part Time)
2013: Attending Doctor and Director of Chemotherapy Institute, Assuta MC, Haifa. (Part time)
2010: Foundation and Consultant, Department of oncology, Holy Family Hospital, Nazareth.  (Part time)
2007: Foundation and Director of the Community Oncology Program, Clalit Health Services. Nazareth. (Part time)
2007-2013: Attending Doctor , Oncology Institute, Rambam MC,Haifa. (Part time)
2001-2007: Residency in Oncology, Rambam Medical Center, Haifa.
2000-2001: Internship, Rambam Medical Center, Haifa, Israel

Education:

1992-1999: The Bruce Rappaport Faculty of Medicine, Technion institute of Technology, Haifa, Israel. M.D. degree
2004: Israeli Board Examination in Oncology, Part I
2007: Israeli Board Examination in Oncology, Part II

 

Dr. Mirjana Rajer, Slovenia I Conference Co-Chair

Assistant Professor Mirjana Rajer, MD, PhD graduated from the Faculty of Medicine at the University of Ljubljana in 2001. She works at the Institute of Oncology Ljubljana and for two years she worked at University Clinic Golnik, Slovenia. Her main clinical work consists of treatment of lung cancer and mesothelioma patients. Beside clinical work, she is involved as principal and co-investigator in several clinical trials of lung cancer, palliative care and communication with cancer patients. She is the editor of national and international journals and author of numerous published papers, book chapters and books; of the most noticeable is the book “New challenges in communication with cancer patients” published by editorial house Springer, where she is one of the co-editors and authors. Being a student’s mentor, she is actively involved in education and she acts as active member of research organizations EORTC, ESMO, IASLC and Central European Initiative against Lung Cancer.